Ornella Garrone
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 169 publications
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.
Journal: Nature communications
Published: April 15, 2026
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
The prognostic impact of pregnancy-associated melanoma on overall and melanoma-specific survival: A systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: February 26, 2026
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study.
Journal: Breast (Edinburgh, Scotland)
Published: February 22, 2026
Does Glucose-6-Phosphate Dehydrogenase Deficiency Correlate with Increased Sensitivity to Cisplatin? A Case Report and a Narrative Literature Review.
Journal: International journal of molecular sciences
Published: February 21, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 23, 2025
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists.
Journal: Current oncology (Toronto, Ont.)
Published: November 05, 2025
Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.
Journal: Med (New York, N.Y.)
Published: September 19, 2025
Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review.
Journal: Journal of cancer research and clinical oncology
Published: September 16, 2025
Last Updated: 09/26/2026